World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon

Novavax at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

Novavax takes part in 2 sessions at World Vaccine Congress Europe 2026 in Amsterdam, and exhibits. Its sessions cover next-generation vaccine technology and its own protein-based approach. The most concrete looks at the potential of the Novavax technology platform, including its Matrix-M adjuvant.

OrganizationWorld Vaccine Congress Europe 2026 Attendance
Novavax
Gaithersburg, MD
Large pharmaAssociate sponsor
Vaccine company developing protein-based vaccines with its Matrix-M adjuvant, including a marketed COVID-19 vaccine.
Booth
Exhibiting (no floor booth listed)
Talk
Tue Oct 20
09:00
The Technology Revolution: Agility for the Wave of Next Generation Vaccines
Which newer vaccine platforms, such as RNA, could shorten outbreak response times and extend vaccines to cancer and autoimmune disease.
with European Medicines Agency, Vaccines Europe, International Vaccine Institute +4 more
Platforms & delivery
Talk
Wed Oct 21
14:00
The Potential of Novavax’s Technology Platform, including Matrix-M® adjuvant
Emerging & Infectious Diseases

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Novavax

Tell us what you sell and we’ll find the people at Novavax most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction